Thiazolobenzimidazole: Biological and biochemical anti-retroviral activity of a new nonnucleoside reverse transcriptase inhibitor
- 31 July 1993
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 21 (3), 247-265
- https://doi.org/10.1016/0166-3542(93)90031-d
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Identification of the human immunodeficiency virus reverse transcriptase residues that contribute to the activity of diverse nonnucleoside inhibitorsAntimicrobial Agents and Chemotherapy, 1992
- Differential inhibitory effects of TIBO derivatives on different strains of simian immunodeficiency virusJournal of General Virology, 1992
- Antiretroviral therapy: reverse transcriptase inhibitionAntimicrobial Agents and Chemotherapy, 1992
- Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase: Nevirapine as a Prototype DrugAIDS Research and Human Retroviruses, 1992
- Characterization of an HIV-1 Isolate Displaying an Apparent Absence of Virion-Associated Reverse Transcriptase ActivityAIDS Research and Human Retroviruses, 1991
- Spectrum of biological properties of human immunodeficiency virus (HIV-1) isolatesVirology, 1990
- Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivityBiochemical Pharmacology, 1987
- Molecular characterization of a polymerase mutant human immunodeficiency virusVirology, 1987
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983